Equities research analysts expect Danaher Co. (NYSE:DHR) to report earnings per share of $1.08 for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Danaher’s earnings. The highest EPS estimate is $1.10 and the lowest is $1.05. Danaher reported earnings of $1.00 per share during the same quarter last year, which indicates a positive year over year growth rate of 8%. The business is scheduled to issue its next earnings report on Thursday, October 18th.
On average, analysts expect that Danaher will report full-year earnings of $4.49 per share for the current financial year, with EPS estimates ranging from $4.43 to $4.56. For the next year, analysts anticipate that the business will report earnings of $4.85 per share, with EPS estimates ranging from $4.40 to $5.00. Zacks’ EPS calculations are an average based on a survey of analysts that cover Danaher.
Danaher (NYSE:DHR) last released its quarterly earnings results on Thursday, July 19th. The conglomerate reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.06. The company had revenue of $4.98 billion for the quarter, compared to the consensus estimate of $4.91 billion. Danaher had a net margin of 13.84% and a return on equity of 11.55%. Danaher’s revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.99 EPS.
Several equities analysts have recently issued reports on the stock. Zacks Investment Research cut shares of Danaher from a “hold” rating to a “sell” rating in a research note on Wednesday, June 20th. ValuEngine raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Thursday, July 12th. Finally, Morgan Stanley lifted their price objective on shares of Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a research note on Friday, July 20th. Two investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $108.31.
Shares of DHR traded up $0.46 during mid-day trading on Wednesday, hitting $104.01. The company’s stock had a trading volume of 1,909,400 shares, compared to its average volume of 2,401,812. The stock has a market capitalization of $72.45 billion, a P/E ratio of 25.81, a P/E/G ratio of 1.98 and a beta of 1.03. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.50 and a quick ratio of 1.07. Danaher has a fifty-two week low of $83.03 and a fifty-two week high of $106.08.
In other news, Chairman Mitchell P. Rales bought 1,080 shares of the company’s stock in a transaction dated Tuesday, July 31st. The shares were acquired at an average cost of $102.32 per share, with a total value of $110,505.60. Following the completion of the transaction, the chairman now directly owns 1,827,953 shares in the company, valued at approximately $187,036,150.96. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Daniel L. Comas sold 77,407 shares of Danaher stock in a transaction that occurred on Thursday, July 26th. The stock was sold at an average price of $103.93, for a total transaction of $8,044,909.51. Following the completion of the transaction, the chief financial officer now directly owns 135,218 shares in the company, valued at $14,053,206.74. The disclosure for this sale can be found here. Over the last three months, insiders sold 299,961 shares of company stock worth $30,619,691. 11.90% of the stock is currently owned by insiders.
Institutional investors have recently added to or reduced their stakes in the company. Mount Yale Investment Advisors LLC purchased a new position in shares of Danaher in the first quarter worth approximately $103,000. IMS Capital Management acquired a new stake in shares of Danaher during the second quarter worth approximately $107,000. BerganKDV Wealth Management LLC acquired a new stake in shares of Danaher during the second quarter worth approximately $111,000. Fort L.P. acquired a new stake in shares of Danaher during the second quarter worth approximately $119,000. Finally, Braun Bostich & Associates Inc. boosted its holdings in shares of Danaher by 506.4% during the second quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock worth $121,000 after purchasing an additional 1,023 shares during the period. 76.95% of the stock is currently owned by institutional investors and hedge funds.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Featured Article: Stock Symbol
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.